UK biotech Engitix has raised a $25 million series A extension from existing investor Netherton Investments, investing on behalf of BlueCrest Capital Management co-founder Mike Platt. The funding will ...
Headquartered in Westworks, White City Place, London, UK. Investors include Netherton Investments (a fund investing on behalf of Mike Platt) and Dompé farmaceutici S.P.A. For more information, visit ...
“This review explores our current understanding of how ECM geometry influences the behaviors of both immune cells and tumor cells, which in turn impacts treatment efficacy and cancer evolutionary ...
StimLabs®, a leading regenerative medicine company, announces the launch of Allacor P, the first medical device derived from human umbilical cord extracellular matrix (ECM). Allacor P was awarded an A ...
(Nanowerk Spotlight) The extracellular matrix (ECM) is the complex network of proteins and sugars that provides structural and biochemical support for surrounding cells in the human body. This dynamic ...
New research has uncovered a complex interplay between extracellular matrix (ECM) structure and the transcriptional responses of cancer cells, showing how they alter their gene expression to ‘escape’ ...
Between and around the billions of neurons in the human brain is an equally vital scaffold, the extracellular matrix (ECM). An interlinked net of proteins and sugars that surrounds brain cells, the ...
In a study published in Cell Stem Cell, researchers led by Profs. DAI Jianwu and ZHAO Yannan from the Institute of Genetics and Developmental Biology of the Chinese Academy of Sciences have ...
Amyotrophic lateral sclerosis and frontotemporal dementia are heterogeneous diseases that are difficult to fully model in mice. One of the more common forms is caused by hexanucleotide repeat ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback